生物标志物 生物标志物
Shuo Ni1, Jiaxin Yue2, Yonggand Shi3
1University of Southern California, Los Angeles, CA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
像PI-2620这样的第二代TAU-PET标记剂对评估阿尔茨海默氏病 (AD) 中的皮质下TAU病理有希望. 种族影响这些TAU PET信号,特别是在非西班牙裔白人个体的杏仁体.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 第一代TAU-PET标记剂 (例如AV-1451) 由于在皮层下区域的非目标结合而存在局限性.
- 第二代标记剂 (例如PI-2620,MK-6240) 为皮层下病理提供了更好的特异性.
- 在皮下阿尔茨海默氏症 (AD) 研究中评估新型tau PET标记物的实用性至关重要.
研究的目的:
- 评估PI-2620PET追踪器在检测阿尔茨海默病 (AD) 中皮下病理方面的有效性.
- 调查种族对皮层下皮质PET信号在认知不受损 (CU) 和认知受损 (CI) 个体的影响.
- 为了检查在特定的皮层下大脑结构内的诊断类别和种族之间的TAU PET信号的差异.
主要方法:
- 在健康和衰老大脑研究:健康差异 (HABS-HD) 队列中利用PI-2620标记器的tau PET数据.
- 包括1,492名参与者 (1097CU,395CI) 进行T1加权MRI和tau PET成像,包括多个不同的种族群体.
- 计算的平均标准化摄入值比 (SUVR) 对皮下区域 (大脑皮层,尾皮层,皮层等) 的平均标准化摄入值比. 使用FreeSurfer细分的方法.
主要成果:
- 在诊断类别的尾状体,海马体和杏仁体中发现了tau SUVR的显著差异.
- 在认知不受损和认知受损组之间观察到皮层下皮质PET信号的种族差异.
- 非西班牙裔白人参与者在骨,海马和杏仁体中表现出显著的差异;黑人参与者在尾状体中;西班牙裔参与者在杏仁体中.
结论:
- 种族显著影响在认知上不受损的和受损的个体中的皮质下皮质PET信号.
- PI-2620标记器显示了在不同人群中评估皮质下病理的潜力.
- 在阿尔茨海默病中,特定的皮层下区域,如杏仁体,表现出受种族影响的差异性积.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


